Tech Company Financing Transactions
Nucleai Funding Round
Nucleai closed a $33 million Series B investment round on 3/24/2022. Backers included Sanofi-Genzyme BioVentures, Section 32 and Debiopharm Diagnostics.
Transaction Overview
Sanofi-Genzyme BioVentures (Lead Investor) (Cris De Luca)
Section 32 (Lead Investor) (Andrew Harrison)
Debiopharm Diagnostics (Tanja Dowe)
Company Information
Chicago, IL 60607
USA
Management Team
Browse more venture capital transactions:
Prev: 3/24/2022: Precirix venture capital transaction
Next: 3/24/2022: Weglot venture capital transaction
Share this article
Where The Data Comes From
We do our best to document funding rounds that are announced publicly. VC transactions reported here come from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs